This is the authors' abstract. We don't add key points for this paper.
Introduction: Exophytic hepatocellular carcinoma (HCC) need a multidisciplinary approach management tailored to individual patient for a better outcome. Microwave ablation is one of the commonly used ablative modality to treat HCCs. Objective: The aim of this study was to evaluate the efficacy of percutaneous microwave ablation (MWA) for exophytic HCC. Methods: A prospective study was conducted on 40 cases with exophytic HCC. Microwave ablation was performed percutaneously for all patients with followed up. Results: 80 % of cases showed complete ablation while 20 % of cases have incomplete ablation. Only 18.8 % of cases showed recurrence while no recurrence in 81.2 % of cases. The complications of MWA were reported by 15 % of cases and were minor complications. There was significant decrease in alpha fetoprotein (AFP) after MWA. Conclusion: This study showed that microwave ablation can be safely performed for exophytic HCCs with effective and satisfactory outcomes. Results: 80 % of cases showed complete ablation while 20 % of cases have incomplete ablation. Only 18.8 % of cases showed recurrence while no recurrence in 81.2 % of cases. The complications of MWA were reported by 15 % of cases and were minor complications. There was significant decrease in alpha fetoprotein (AFP) after MWA. Conclusion: This study showed that microwave ablation can be safely performed for exophytic HCCs with effective and satisfactory outcomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Said et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: